EUVIMEDEUVIMED entdecken
Open Access

Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases

Christophe Le Terrier iD, Clément Viguier, Patrice Nordmann iD, Alejandro J Vila iD, Laurent Poirel iD

Antimicrobial Agents and Chemotherapy · 07.02.2024 · 68 (2)

DOI: 10.1128/aac.00991-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 07.02.2024. Verfasst von Christophe Le Terrier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Emerging Antibiotic Resistance, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland. Hauptthemen laut MEDLINE: beta-Lactamases, Borinic Acids. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University of Fribourg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Taniborbactam (TAN) is a novel broad-spectrum β-lactamase inhibitor with significant activity against subclass B1 metallo-β-lactamases (MBLs). Here, we showed that TAN exhibited an overall excellent activity against B1 MBLs including most NDM- and VIM-like as well as SPM-1, GIM-1, and DIM-1 enzymes, but not against SIM-1. Noteworthy, VIM-1-like enzymes (particularly VIM-83) were less inhibited by TAN than VIM-2-like. Like NDM-9, NDM-30 (also differing from NDM-1 by a single amino acid substitution) was resistant to TAN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBorinic Acidsbeta-Lactamase InhibitorsCarboxylic AcidsAnti-Bacterial AgentsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

IMPNDMVIMmetallo-β-lactamasetaniborbactam

Substanzen

beta-Lactamasesbeta-Lactamase InhibitorstaniborbactamBorinic AcidsCarboxylic AcidsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Emerging Antibiotic Resistance, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
  • Division of Intensive Care Unit, University Hospitals of Geneva, Geneva, Switzerland.
  • Infectious Disease Department, University Hospital of Toulouse, Toulouse, France.
  • Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), Fribourg, Switzerland.
  • Instituto de Biología Molecular y Celular de Rosario (IBR, CONICET-UNR), Rosario, Argentina.
  • Área Biofísica, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina.

ORCID-Profile: Christophe Le Terrier, Patrice Nordmann, Alejandro J Vila, Laurent Poirel

Förderung

  • University of Fribourg

Zitieren

APA

Le Terrier, C., Viguier, C., Nordmann, P., Vila, A. J., & Poirel, L. (2024). Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases. Antimicrobial Agents and Chemotherapy, 68(2). https://doi.org/10.1128/aac.00991-23

Vancouver

Le Terrier C, Viguier C, Nordmann P, Vila AJ, Poirel L. Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases. Antimicrobial Agents and Chemotherapy. 2024;68(2). doi:10.1128/aac.00991-23

BibTeX
@article{LeTerrier2024,
  author = {Le Terrier, Christophe and Viguier, Clément and Nordmann, Patrice and Vila, Alejandro J and Poirel, Laurent},
  title = {Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  volume = {68},
  number = {2},
  doi = {10.1128/aac.00991-23}
}
Kostenlos starten →